Publications

Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia.

MACKENZIE, GA; BOTTOMLEY, C; VAN HOEK, AJ; JEFFRIES, D; Ota, M; ZAMAN, SM A; GREENWOOD, B; Cutts, F;

2014

Vaccine, (2014).32 21 10.1016/j.vaccine.2014.02.081.

Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

BAGUELIN, M; FLASCHE, S; CAMACHO, A; Demiris, N; MILLER, E; EDMUNDS, WJ;

2013

PLoS medicine, (2013).10 10 10.1371/journal.pmed.1001527.

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

CUCCUI, J; Thomas, RM; MOULE, MG; D'Elia, RV; Laws, TR; Mills, DC; Williamson, D; Atkins, TP; Prior, JL; WREN, BW;

2013

Open biology, (2013).3 5 10.1098/rsob.130002.

Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial.

ROCA, A; Dione, MM; BOJANG, A; Townend, J; Egere, U; Darboe, O; Howie, SR C; Hill, PC; Adegbola, RA; GREENWOOD, BM; ANTONIO, M;

2013

PLOS ONE, (2013).8 9 10.1371/journal.pone.0072198.

A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.

Draper, E; Bissett, SL; Howell-Jones, R; Waight, P; Soldan, K; JIT, M; Andrews, N; MILLER, E; Beddows, S;

2013

PloS one, (2013).8 5 10.1371/journal.pone.0061825.

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Daugla, DM; Gami, JP; Gamougam, K; Naibei, N; Mbainadji, L; Narbé, M; Toralta, J; Kodbesse, B; Ngadoua, C; Coldiron, ME; Fermon, F; Page, A-L; Djingarey, MH; Hugonnet, S; Harrison, OB; Rebbetts, LS; Tekletsion, Y; Watkins, ER; Hill, D; Caugant, DA; CHANDRAMOHAN, D; Hassan-King, M; MANIGART, O; NASCIMENTO, M; Woukeu, A; ... GREENWOOD, BM.

2013

Lancet, (2013).383 9911 10.1016/S0140-6736(13)61612-8.

Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination.

Dunne, EM; Smith-Vaughan, HC; Robins-Browne, RM; MULHOLLAND, EK; Satzke, C;

2013

Vaccine, (2013).31 19 10.1016/j.vaccine.2013.03.024.

Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomise...

O'Grady, K-AF; Grimwood, K; Cripps, A; MULHOLLAND, EK; Morris, P; Torzillo, PJ; Wood, N; Smith-Vaughan, H; Revell, A; Wilson, A; Van Asperen, P; Richmond, P; Thornton, R; Rablin, S; Chang, AB;

2013

Trials, (2013).14, 10.1186/1745-6215-14-282.

Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease.

Hargreaves, CE; Grasso, M; Hampe, CS; Stenkova, A; ATKINSON, S; JOSHUA, GW P; WREN, BW; Buckle, AM; Dunn-Walters, D; Banga, JP;

2013

Journal of immunology (Baltimore, Md, (2013).190 11 10.4049/jimmunol.1203412.

[Medium-term acceptability of HIV vaccine clinical trials in Burkina Faso: stakeholders' perceptions].

Berthé, A; Traore, I; Berthé-Sanou, L; Somé, J; Salouka, S; Rouamba, J; MAYAUD, P; Nagot, N; Meda, N;

2013

Sante publique (Vandoeuvre-les-Nancy, France), (2013).25 5 10.3917/spub.135.0675.